Alka Chaubey - Jun 3, 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Jun 3, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/5/2024, 05:40 PM
Previous filing: Mar 5, 2024
Next filing: Sep 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Award	$0	+16K	+49.62%	$0.00	48.2K	Jun 3, 2024	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+75K		$0.00	75K	Jun 3, 2024	Common Stock	75K	$0.93	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2	The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.
F3	Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023 and 608 shares acquired under the ESPP from previous years.
F4	The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.